ASCLS eNewsBytes

• What are the new XEC COVID variant symptoms and when will it hit the US? September 24, 2024
  XEC, an Omicron variant of COVID-19, is spreading in Europe and the U.S. It has spike mutations, making it more infectious than previous strains. Symptoms include fever, chills and coughing. Early reports suggest no significant differences from other COVID-19 strains.
• A two-dose schedule could make HIV vaccines more effective September 24, 2024
  A new study by MIT researchers has found that a series of escalating doses of an HIV vaccine can generate larger quantities of neutralizing antibodies, overcoming the challenge of rapid virus mutations. The researchers found that a similar immune response can be achieved with just two doses, given one week apart.
• Lipid metabolism plays a critical role in red blood cell recovery from acute anemia September 24, 2024
  Researchers have discovered that hematopoietic stem cells, which produce all blood cells but lack receptors for erythropoietin, respond to severe anemia. They found that genes related to lipid metabolism, particularly the VLDL receptor, are activated shortly after anemia onset.
• Medical swabs market is set to experience a revolutionary growth September 24, 2024
  SkyQuest Technology Group's study on the Medical Swabs Market provides a comprehensive analysis of the market, including competitor and geographical analysis. The market is expected to grow at a CAGR of 6.9% from 2024-2031, driven by factors like an aging global population, technological advancements and rising global expenditure.
• Prostate cancer genetic testing lagging despite benefits September 24, 2024
  Genetic testing for prostate cancer patients, particularly those with mutations in DNA repair genes like BRCA2, has been slow to be implemented, despite its potential to improve clinical management and develop novel therapies.